本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Clearmind Medicine, Inc.

0.2699
-0.0153-5.36%
成交量:919.28萬
成交額:240.83萬
市值:147.54萬
市盈率:-0.32
高:0.2700
開:0.2600
低:0.2500
收:0.2852
52周最高:2.18
52周最低:0.2400
股本:546.64萬
流通股本:531.86萬
量比:2.46
換手率:172.84%
股息:- -
股息率:- -
每股收益(TTM):-0.8560
每股收益(LYR):-1.6950
淨資產收益率:-178.64%
總資產收益率:-59.68%
市淨率:1.38
市盈率(LYR):-0.16

資料載入中...

2025/09/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/01/22

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/12/09

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/03/27

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/03/19

SEC問詢函

Form CORRESP - Correspondence
2024/03/18

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/02/14

SEC問詢函

Form CORRESP - Correspondence
2024/02/14

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/07

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/06

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/29

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/01/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/27

SEC問詢函

Form CORRESP - Correspondence
2023/09/14

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/09/13

SEC問詢函

Form CORRESP - Correspondence
2023/09/06

SEC問詢函

Form CORRESP - Correspondence
2023/09/05

SEC問詢函

Form CORRESP - Correspondence
2023/09/05

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/07/27

SEC問詢函

Form CORRESP - Correspondence